| 发明名称 | Oral composition | ||
| 摘要 | The present invention provides an oral composition comprising hydroxyapatite, potassium nitrate, and calcium monohydrogen phosphate, wherein the composition has an increased ability to occlude dentinal tubules of a tooth and has an excellent inhibitory effect on hypersensitivity. | ||
| 申请公布号 | US9468593(B2) | 申请公布日期 | 2016.10.18 |
| 申请号 | US201314425537 | 申请日期 | 2013.09.04 |
| 申请人 | Kabushiki Kaisha Sangi | 发明人 | Saito Tomoki;Kawamata Hiroyuki;Ota Kazushi;Sakuma Shuji |
| 分类号 | A61Q11/00;A61K8/24;A61K9/14;A61K45/06;A61K8/18;A61K8/19 | 主分类号 | A61Q11/00 |
| 代理机构 | Norton Rose Fulbright US LLP | 代理人 | Norton Rose Fulbright US LLP |
| 主权项 | 1. A method for suppressing hypersensitivity, comprising contacting an oral composition comprising 0.5 to 20% by weight of hydroxyapatite having an average particle size of 0.01 to 10 μm, 2.5 to 10% by weight of potassium nitrate, and 0.5 to 25% by weight of calcium monohydrogen phosphate dihydrate to dentin of a tooth in an oral cavity of a subject in need of increasing an ability to occlude dentinal tubules of a tooth. | ||
| 地址 | Tokyo JP | ||